Clinical Trials Browser

Interventional × Lymphoma × crolibulin × Clear all

NCT00423410 2009-09-10

A Safety Study of EPC2407, A Anti-Cancer Drug With Vascular Disrupting Activity: In Patients With Advanced Cancer

Phase 1 Completed

Lymphoma, Neoplasms